Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist vs Antagonist Ovarian Stimulation in PCOS
NCT00417144Phase 4Unknown
- Sponsor
- Eugonia
- Start
- Nov 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ganirelix in ovarian hyperstimulation syndrome (OHSS), polycystic ovary syndrome (PCOS), sponsored by Eugonia. Status: unknown.
02
Drugs
ganirelix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT00417144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417144.